Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
F SaiaPatrick W Serruys

Abstract

The purpose of this study was to compare the mid-term clinical outcome of sirolimus-eluting stent (SES) implantation and vascular brachytherapy (VBT) for in-stent restenosis (ISR). We assessed the 9-month occurrence of major adverse cardiac events (MACE) in 44 consecutive patients with ISR treated with SES implantation and 43 consecutive patients treated with VBT in the period immediately prior. Baseline clinical and angiographic characteristics of the two groups were similar. During follow-up, three patients (7%) died in the VBT group and none in the SES group. The incidence of myocardial infarction was 2.3% in both groups. Target lesion revascularization was performed in 11.6% of the VBT patients and 16.3% of the SES patients (P = NS). The 9-month MACE-free survival was similar in both groups (79.1% VBT vs. 81.5% SES; P = 0.8 by log rank). The result of this nonrandomized study suggests that sirolimus-eluting stent implantation is at least as effective as vascular brachytherapy in the treatment of in-stent restenosis.

References

Jun 12, 1997·The New England Journal of Medicine·P S TeirsteinP Tripuraneni
Aug 24, 1999·Circulation·M A CostaP W Serruys
Nov 7, 1999·Journal of the American College of Cardiology·P N RuygrokP W Serruys
Apr 12, 2000·Journal of the American College of Cardiology·A M LincoffE J Topol
Jul 18, 2000·Journal of the American College of Cardiology·R WaksmanM B Leon
Jan 9, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·S GiriJ J Popma
Feb 15, 2001·The New England Journal of Medicine·M B LeonR E Kuntz
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Jan 15, 2002·Journal of the American College of Cardiology·Harry C LoweLevon M Khachigian
Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie
Jan 22, 2003·Journal of the American College of Cardiology·Muzaffer DegertekinPatrick W Serruys
Jun 25, 2003·Circulation·Pedro A LemosJ Eduardo Sousa
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators

❮ Previous
Next ❯

Citations

Oct 1, 2005·Cardiovascular and Interventional Radiology·Paul ErneTherese J Resink
Mar 5, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Helge MöllmannChristian W Hamm
May 26, 2005·Current Treatment Options in Cardiovascular Medicine·William W Chu, Ron Waksman
Dec 8, 2006·The Canadian Journal of Cardiology·Gordon E PateChristopher E Buller
Feb 3, 2006·The New England Journal of Medicine·Patrick W SerruysAndrew T L Ong
Feb 24, 2007·Vascular Health and Risk Management·Thein Htay, Ming W Liu
Nov 2, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Rosli Mohd AliMartin Unverdorben
Jan 23, 2009·Journal of Vascular and Interventional Radiology : JVIR·David A BrownStephen T Kee
Jan 15, 2008·International Journal of Cardiology·Seong-Wook ParkSeung-Jung Park
May 30, 2006·Hematology/oncology Clinics of North America·Tony Y EngC R Thomas
Jun 20, 2006·Cardiology Clinics·Jeffrey J Popma, Mark Tulli
Nov 5, 2004·The Journal of Pharmacy and Pharmacology·Peter BirkenhauerBruno Gander
Aug 19, 2008·Journal of Interventional Cardiology·Konstantinos ToutouzasChristodoulos Stefanadis
Jun 1, 2011·The American Journal of Cardiology·Mohammad AlmallaRainer Hoffmann
Nov 3, 2005·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Bryan P Y YanRon Waksman
May 26, 2009·JACC. Cardiovascular Interventions·David R HolmesUNKNOWN SISR Investigators
Jul 5, 2005·International Journal of Cardiology·Claude Le FeuvreJean Philippe Metzger
Mar 17, 2005·European Heart Journal·Sigmund SilberUNKNOWN Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Jun 30, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ron Waksman
Oct 27, 2004·Current Opinion in Cardiology·Grzegorz L Kaluza, Albert E Raizner
Jun 24, 2005·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Richard E WatersMichael H Sketch
Jul 8, 2005·Coronary Artery Disease·Jorge A BelardiLiliana Grinfeld
Sep 15, 2005·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Franz-Josef Neumann
Aug 19, 2007·Journal of Cardiovascular Medicine·Nedy BrambillaLuigi Tavazzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.